Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -442.4% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 16.4 | n/a |
Pr/Book | 2.3 |
Latest | F'cast | |
---|---|---|
Revenue | 107.5% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1.70 | (3.51) | (17.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.16 | (6.95) | (27.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 2.40 | (10.54) | (32.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Arecor and TRx Biosciences research collaboration | 12-Mar-2024 | 08:58 | RNS |
Arecor announces launch of Ogluo® in ... | 29-Feb-2024 | 07:00 | RNS |
Year End Trading Update | 01-Feb-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 128.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 270.00 |
52 Week Low | 127.00 |
Volume | 3,300 |
Shares Issued | 30.63m |
Market Cap | £39.36m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:59 | 252 @ 128.80p |
11:52 | 546 @ 127.50p |
09:24 | 500 @ 127.00p |
08:09 | 2,000 @ 127.00p |
08:00 | 2 @ 130.00p |
CEO | Sarah Jennifer Howell |
CFO | Susan Lowther |
You are here: research